2022 annual financial data
Viridian Therapeutics 2022 Operating margin
Direct answer
Operating margin was -7,579.23%.
Operating income was -134,304,000 USD and net income was -129,874,000 USD.
Operating cash flow was -93,838,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,772,000 USD
- Operating income
- -134,304,000 USD
- Net income
- -129,874,000 USD
- Operating cash flow
- -93,838,000 USD